At a glance
- Originator Scios
- Developer Nonindustrial source; Scios
- Class Analgesics; Imidazoles; Spiro compounds
- Mechanism of Action Bradykinin B2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 31 Aug 1998 No-Development-Reported for Pain in Brazil (Unknown route)
- 31 Aug 1998 No-Development-Reported for Pain in USA (Unknown route)
- 08 May 1996 Preclinical development for Pain in Brazil (Unknown route)